Page last updated: 2024-08-26

fotemustine and Lung Neoplasms

fotemustine has been researched along with Lung Neoplasms in 25 studies

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19901 (4.00)18.7374
1990's15 (60.00)18.2507
2000's6 (24.00)29.6817
2010's3 (12.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Addeo, R; Caraglia, M; Facchini, S; Luce, A; Zappavigna, S1
Bedane, C; Combemale, P; Cupissol, D; Derrey, S; Dygai-Cochet, I; Lamant, L; Leccia, MT; Lubrano, V; Mazeau-Woynar, V; Mirabel, X; Modiano, P; Mourrégot, A; Planchamp, F; Rougé Bugat, ME; Sassolas, B; Siegrist, S; Thariat, J; Tiffet, O; Truc, G; Verdoni, L1
Jorda, E; Lopez, V; Marti, N; Monteagudo, C; Pinazo, I1
Adamo, V; Calista, F; Carrozza, F; Cigolari, S; Colucci, G; Ferraù, F; Galetta, D; Gebbia, V; Russo, P; Silvestris, N1
Eigentler, TK; Garbe, C1
Friedlander, M; Kurtovic, J; Riordan, SM; Singh-Grewal, I; Webster, GJ1
Bajetta, E; Canova, S; Del Vecchio, M; Messina, A1
Grant, SC; Kris, MG1
Astoul, P; Boutin, C; Juin, P; Muracciole, X; Orabona, P; Pignon, T; Ruggieri, S; Vialette, JP1
Berille, J; Bertrand, P; Bizzari, JP; Cour, V; Gerard, B; Giroux, B; Khayat, D; Sarkany, M1
Allen, R; Berille, J; Rudd, R; Souhami, RL; Spiro, SG; Trask, C1
Baio, S; Berille, J; Le Cesne, A; Le Chevalier, T; Rivière, A1
Berille, J; Bizzari, JP; Cerrina, ML; Douillard, JY; Gouva, S; Grandgirard, A; Le Chevalier, T; Monnier, A; Pujol, JL; Rivière, A1
Chaitchik, S; Merimsky, O1
Aamdal, S; Bizzari, JP; D'Incalci, M; Gerard, B; Lee, SM; Leyvraz, S; Lucas, C1
Baud, M; Bérille, J; Chabot, G; Gouyette, A; Le Cesne, A; Le Chevalier, T; Lucas, C; Marty, M1
Berille, J; Brune, J; Cotto, C; Croisile, B; Giroux, B; Riou, R; Souquet, PJ; Trillet-Lenoir, V; Turjman, F1
Binder, M; Pehamberger, H; Seeber, A; Steiner, A; Wolff, K1
Becker, JC; Bröcker, EB; Kämpgen, E; Terheyden, P1
Bock, M; Deichmann, M; Jäckel, A; Näher, H; Waldmann, V1
Boaziz, C1
Avril, MF; Bertrand, P; Bizzari, JP; Cour, V; Gerard, B; Khayat, D1
Berille, J; Berlion, M; Bizzari, JP; Fischel, JL; Formento, P; Gioanni, J; Milano, G2
Berille, J; Berthaud, P; Cerrina, ML; Gouva, S; Le Chevalier, T; Prache, C; Quoix, E; Riviere, A; Zabbe, C1

Reviews

7 review(s) available for fotemustine and Lung Neoplasms

ArticleYear
Chemotherapy in the management of brain metastases: the emerging role of fotemustine for patients with melanoma and NSCLC.
    Expert opinion on drug safety, 2013, Volume: 12, Issue:5

    Topics: Antineoplastic Agents; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Lung Neoplasms; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds

2013
[Therapy of malignant melanoma at the stage of distant metastasis].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2004, Volume: 55, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Brain Neoplasms; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dacarbazine; Disease Progression; Humans; Immunotherapy; Interferon-alpha; Interleukin-2; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Melanoma; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Palliative Care; Prognosis; Radiotherapy Dosage; Randomized Controlled Trials as Topic; Skin Neoplasms; Temozolomide; Time Factors; Tomography, X-Ray Computed; Vindesine

2004
New antineoplastic agents in lung cancer 1988-1993.
    Cancer treatment and research, 1995, Volume: 72

    Topics: Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Clinical Trials as Topic; Humans; Irinotecan; Lung Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds; Paclitaxel; Teniposide; Vinblastine; Vinorelbine

1995
Fotemustine in the treatment of brain primary tumors and metastases.
    Cancer investigation, 1994, Volume: 12, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Glioma; Humans; Lung Neoplasms; Melanoma; Middle Aged; Multicenter Studies as Topic; Nitrosourea Compounds; Organophosphorus Compounds

1994
[Therapy of metastatic malignant uveal melanoma].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2001, Volume: 52, Issue:2

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Chemoembolization, Therapeutic; Female; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Male; Melanoma; Middle Aged; Multicenter Studies as Topic; Neoplasm Metastasis; Nitrosourea Compounds; Organophosphorus Compounds; Prognosis; Skin Neoplasms; Time Factors; Uveal Neoplasms

2001
[Contribution of a new nitrosourea compound: fotemustine].
    Pathologie-biologie, 1992, Volume: 40, Issue:9 Pt 2

    Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cisplatin; Dacarbazine; Drug Therapy, Combination; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds

1992
Fotemustine: an overview of its clinical activity in disseminated malignant melanoma.
    Melanoma research, 1992, Volume: 2, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Lung Neoplasms; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds; Recombinant Proteins; Remission Induction; Vindesine

1992

Trials

9 trial(s) available for fotemustine and Lung Neoplasms

ArticleYear
Cisplatin, fotemustine and whole-brain radiotherapy in non-small cell lung cancer patients with asymptomatic brain metastases: a multicenter phase II study of the Gruppo Oncologico Italia Meridionale (GOIM 2603).
    Lung cancer (Amsterdam, Netherlands), 2011, Volume: 72, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Female; Humans; Italy; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Treatment Outcome

2011
Phase II study of fotemustine in untreated inoperable non-small-cell lung cancer.
    Cancer chemotherapy and pharmacology, 1994, Volume: 34, Issue:5

    Topics: Aged; Anemia; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Quality of Life; Thrombocytopenia

1994
Cisplatin-fotemustine combination in inoperable non-small cell lung cancer: preliminary report of a French multicentre phase II trial.
    European journal of cancer (Oxford, England : 1990), 1994, Volume: 30A, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Nausea; Nitrosourea Compounds; Organophosphorus Compounds; Vomiting

1994
Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancer.
    British journal of cancer, 1994, Volume: 69, Issue:6

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Central Nervous System Neoplasms; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Nitrosourea Compounds; Organophosphorus Compounds; Prognosis; Quality of Life; Survival Analysis; Time Factors

1994
Phase I-II and pharmacokinetic study of a new fotemustine schedule in advanced non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 1995, Volume: 13, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds

1995
A phase II trial of fotemustine and cisplatin in central nervous system metastases from non-small cell lung cancer.
    European journal of cancer (Oxford, England : 1990), 1996, Volume: 32A, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Cisplatin; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Survival Rate

1996
Sequential interferon-alpha2b, interleukin-2 and fotemustine for patients with metastatic melanoma.
    Melanoma research, 2000, Volume: 10, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Disease-Free Survival; Female; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-2; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Recombinant Proteins; Skin Neoplasms; Survival Rate

2000
Fotemustine: an overview of its clinical activity in disseminated malignant melanoma.
    Melanoma research, 1992, Volume: 2, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Dacarbazine; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Lung Neoplasms; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds; Recombinant Proteins; Remission Induction; Vindesine

1992
Phase II multicentre study of the nitrosourea fotemustine in inoperable squamous cell lung carcinoma.
    European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:11

    Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Multicenter Studies as Topic; Nitrosourea Compounds; Organophosphorus Compounds

1989

Other Studies

10 other study(ies) available for fotemustine and Lung Neoplasms

ArticleYear
[Management of patients with metastatic cutaneous melanoma: French national guidelines. French National Cancer Institute].
    Annales de dermatologie et de venereologie, 2014, Volume: 141, Issue:2

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; Bone Neoplasms; Brain Neoplasms; Combined Modality Therapy; Dacarbazine; Disease Management; France; Humans; Indoles; Ipilimumab; Liver Neoplasms; Lung Neoplasms; Melanoma; Molecular Targeted Therapy; Neoplasm Staging; Nitrosourea Compounds; Oncogenes; Organophosphorus Compounds; Proto-Oncogene Proteins B-raf; Skin Neoplasms; Sulfonamides; Temozolomide; Vemurafenib

2014
Follicular hyperplasia on the face subsequent to therapy with sorafenib. A new skin side effect.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:8

    Topics: Aged, 80 and over; Antineoplastic Agents; Benzenesulfonates; Humans; Hyperplasia; Lung Neoplasms; Male; Melanoma; Niacinamide; Nitrosourea Compounds; Organophosphorus Compounds; Phenylurea Compounds; Pyridines; Skin; Skin Diseases; Skin Neoplasms; Sorafenib

2009
Prevention of hepatotoxicity but loss of antimelanoma effect with combined fotemustine and anti-oxidant treatment.
    Internal medicine journal, 2004, Volume: 34, Issue:5

    Topics: Acetylcysteine; Adult; Antineoplastic Agents; Antioxidants; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Female; Humans; Liver; Lung Neoplasms; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds; Treatment Outcome

2004
Impressive objective response in a patient with extensive metastatic melanoma including the brain.
    Melanoma research, 2007, Volume: 17, Issue:5

    Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Female; Humans; Lung Neoplasms; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds; Tomography, X-Ray Computed

2007
[Association of radiation- and fotemustine-therapy in the management of brain metastases from non-small-cell cancers of the lung].
    Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique, 1994, Volume: 81, Issue:1

    Topics: Aged; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Humans; Lung Neoplasms; Male; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Prognosis; Survival Analysis

1994
Fotemustine-dacarbazine combinations in the treatment of metastatic melanoma.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Humans; Liver Neoplasms; Lung Neoplasms; Melanoma; Nitrosourea Compounds; Organophosphorus Compounds

1993
Activity and unexpected lung toxicity of the sequential administration of two alkylating agents--dacarbazine and fotemustine--in patients with melanoma.
    European journal of cancer (Oxford, England : 1990), 1993, Volume: 29A, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Female; Humans; Lung; Lung Neoplasms; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Respiratory Distress Syndrome

1993
Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine.
    European journal of cancer (Oxford, England : 1990), 1998, Volume: 34, Issue:13

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Nitrosourea Compounds; Organophosphorus Compounds; Skin Neoplasms; Treatment Outcome

1998
[Cytotoxic effects of the combination of a new nitrosourea, fotemustine, combined with 5-fluorouracil and folinic acid depend on the sequence of their administration].
    Bulletin du cancer, 1992, Volume: 79, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Antagonism; Drug Synergism; Fluorouracil; Humans; Leucovorin; Lung Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds; Tumor Cells, Cultured

1992
Sequence-dependent cytotoxic effects of the combination of a new nitrosourea, fotemustine, with 5-fluorouracil plus folinic acid.
    Cancer chemotherapy and pharmacology, 1991, Volume: 28, Issue:6

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Line; Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Interactions; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Leucovorin; Lung Neoplasms; Nitrosourea Compounds; Organophosphorus Compounds; Tumor Cells, Cultured

1991